Mysthera Therapeutics AG use PIM kinase treating patients suffering with complex autoimmune disorders and Forty51 Ventur...
Biotech, Enea Foundation acquires business unit of Holostem Terapie Avanzate
The Enea Tech and Biomedical Foundation, a private law foundation supervised by Mimit, has formally acquired Holostem, a...
Half of drugs in experimentation are biotech. Greco (Assobiotec): A shared vision is crucial
Currently, 50% of the drugs in experimentation are biotechnological. Within a few years, eight out of 10 drugs will be b...
ITTBioMed: the platform to enhance innovation and technology transfer
The weight of biotech in the pharmaceutical sciences is growing from 20% of the drugs produced in 2012 will constitute 8...
Innovation for Life Sciences: Road to #JPM24
Join the live session that brings together the competitiveness of Italian Life Sciences and the experience of US Investo...
Global trend in biotech startups
Time is crucial, as even a single day saved in the development of a new medication can have a significant impact on pati...